Effect of disease modifying anti-rheumatic drugs on major cardiovascular events: a meta-analysis of randomized controlled trials

Disease modifying anti-rheumatic drugs (DMARDs) were developed to treat joint inflammation. There is growing evidence that anti-inflammatory drugs prevent major cardiovascular events (MACE). The aim of this systematic review and meta-analysis was to examine whether DMARDs reduce the risk of MACE. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Thanigaimani, Shivshankar, Phie, James, Krishna, Smriti Murali, Moxon, Joseph, Golledge, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987985/
https://www.ncbi.nlm.nih.gov/pubmed/33758292
http://dx.doi.org/10.1038/s41598-021-86128-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987985/
https://www.ncbi.nlm.nih.gov/pubmed/33758292
http://dx.doi.org/10.1038/s41598-021-86128-y

Ejemplares similares